IL6 and neoplasm: Under hypoxic conditions in an immunosuppressive TME, upregulation of IL-6R expression on tumour cells and increased IL-6 production have been reported, inducing M2-TAMs and further promoting tumour progression and expansion, and survival resistance (51, 53, 54).